Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis.

Mougey EB, Williams A, Coyne AJK, Gutiérrez-Junquera C, Fernández-Fernández S, Cilleruelo ML, Rayo A, Echeverría L, Román E, González Lois C, Chao M, Al-Atrash H, Lima JJ, Franciosi JP.

J Pediatr Gastroenterol Nutr. 2019 Nov;69(5):581-587. doi: 10.1097/MPG.0000000000002480.

2.

Fish Oil Supplementation in Overweight/Obese Patients with Uncontrolled Asthma. A Randomized Trial.

Lang JE, Mougey EB, Hossain MJ, Livingston F, Balagopal PB, Langdon S, Lima JJ.

Ann Am Thorac Soc. 2019 May;16(5):554-562. doi: 10.1513/AnnalsATS.201807-446OC.

PMID:
30678465
3.

Genotype tailored treatment of mild symptomatic acid reflux in children with uncontrolled asthma (GenARA): Rationale and methods.

Tang M, Blake KV, Lima JJ, Mougey EB, Franciosi J, Schmidt S, Hossain MJ, Cobbaert M, Fischer BM, Lang JE.

Contemp Clin Trials. 2019 Mar;78:27-33. doi: 10.1016/j.cct.2019.01.009. Epub 2019 Jan 16.

4.

Novel Implementation of Genotype-Guided Proton Pump Inhibitor Medication Therapy in Children: A Pilot, Randomized, Multisite Pragmatic Trial.

Cicali EJ, Blake K, Gong Y, Mougey EB, Al-Atrash H, Chambers N, Denham J, Evans J, George DE, Gomez R, Palomo P, Taufiq S, Johnson JA, Lima JJ, Franciosi JP.

Clin Transl Sci. 2019 Mar;12(2):172-179. doi: 10.1111/cts.12589. Epub 2018 Oct 20.

5.

Association between CYP2C19 extensive metabolizer phenotype and childhood anti-reflux surgery following failed proton pump inhibitor medication treatment.

Franciosi JP, Mougey EB, Williams A, Gomez Suarez RA, Thomas C, Creech CL, George K, Corao D, Lima JJ.

Eur J Pediatr. 2018 Jan;177(1):69-77. doi: 10.1007/s00431-017-3051-4. Epub 2017 Dec 6.

PMID:
29209919
6.

Association Between CYP2C19*17 Alleles and pH Probe Testing Outcomes in Children With Symptomatic Gastroesophageal Reflux.

Franciosi JP, Mougey EB, Williams A, Gomez-Suarez RA, Thomas C, Creech CL, George K, Corao D, Lima JJ.

J Clin Pharmacol. 2018 Jan;58(1):89-96. doi: 10.1002/jcph.977. Epub 2017 Sep 8.

PMID:
28884817
7.

The Duffy antigen receptor for chemokines regulates asthma pathophysiology.

Chapman DG, Mougey EB, Van der Velden JL, Lahue KG, Aliyeva M, Daphtary N, George KL, Hoffman SM, Schneider RW, Tracy RP, Worthen GS, Poynter ME, Peters SP, Lima JJ, Janssen-Heininger YMW, Irvin CG.

Clin Exp Allergy. 2017 Sep;47(9):1214-1222. doi: 10.1111/cea.12949. Epub 2017 Jun 9.

8.

Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.

Lang JE, Holbrook JT, Mougey EB, Wei CY, Wise RA, Teague WG, Lima JJ; American Lung Association-Airways Clinical Research Centers.

Ann Am Thorac Soc. 2015 Jun;12(6):878-85. doi: 10.1513/AnnalsATS.201408-391OC.

9.

Association of CYP2C19 polymorphisms and lansoprazole-associated respiratory adverse effects in children.

Lima JJ, Lang JE, Mougey EB, Blake KB, Gong Y, Holbrook JT, Wise RA, Teague WG.

J Pediatr. 2013 Sep;163(3):686-91. doi: 10.1016/j.jpeds.2013.03.017. Epub 2013 Apr 24.

PMID:
23623526
10.

Nutrigenetic response to omega-3 fatty acids in obese asthmatics (NOOA): rationale and methods.

Lang JE, Mougey EB, Allayee H, Blake KV, Lockey R, Gong Y, Hossain J, Killen K, Lima JJ; Nemours Network for Asthma Research.

Contemp Clin Trials. 2013 Mar;34(2):326-35. doi: 10.1016/j.cct.2012.12.009. Epub 2013 Jan 6.

11.

Pharmacogenetics of asthma controller treatment.

Mougey EB, Chen C, Tantisira KG, Blake KV, Peters SP, Wise RA, Weiss ST, Lima JJ.

Pharmacogenomics J. 2013 Jun;13(3):242-50. doi: 10.1038/tpj.2012.5. Epub 2012 Feb 28.

12.

Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast.

Mougey EB, Lang JE, Wen X, Lima JJ.

J Clin Pharmacol. 2011 May;51(5):751-60. doi: 10.1177/0091270010374472. Epub 2010 Oct 25.

PMID:
20974993
13.

Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response.

Mougey EB, Feng H, Castro M, Irvin CG, Lima JJ.

Pharmacogenet Genomics. 2009 Feb;19(2):129-38. doi: 10.1097/FPC.0b013e32831bd98c.

14.

Growth factor regulation of human growth plate chondrocyte proliferation in vitro.

Olney RC, Wang J, Sylvester JE, Mougey EB.

Biochem Biophys Res Commun. 2004 May 14;317(4):1171-82.

PMID:
15094393
15.

Mitochondrial ribosomal proteins: candidate genes for mitochondrial disease.

Sylvester JE, Fischel-Ghodsian N, Mougey EB, O'Brien TW.

Genet Med. 2004 Mar-Apr;6(2):73-80. Review.

PMID:
15017329
16.

Determination of human beta(2)-adrenoceptor haplotypes by denaturation selective amplification and subtractive genotyping.

Wang J, Mougey EB, David CJ, Humma LM, Johnson JA, Lima JJ, Sylvester JE.

Am J Pharmacogenomics. 2001;1(4):315-22.

PMID:
12083963
17.

Using real-time, quantitative PCR for rapid genotyping of the steroid 21-hydroxylase gene in a north Florida population.

Olney RC, Mougey EB, Wang J, Shulman DI, Sylvester JE.

J Clin Endocrinol Metab. 2002 Feb;87(2):735-41.

PMID:
11836313
18.

Heart-specific splice-variant of a human mitochondrial ribosomal protein (mRNA processing; tissue specific splicing).

Spirina O, Bykhovskaya Y, Kajava AV, O'Brien TW, Nierlich DP, Mougey EB, Sylvester JE, Graack HR, Wittmann-Liebold B, Fischel-Ghodsian N.

Gene. 2000 Dec 31;261(2):229-34.

PMID:
11167009
19.

Mammalian mitochondrial ribosomal proteins (4). Amino acid sequencing, characterization, and identification of corresponding gene sequences.

O'Brien TW, Liu J, Sylvester JE, Mougey EB, Fischel-Ghodsian N, Thiede B, Wittmann-Liebold B, Graack HR.

J Biol Chem. 2000 Jun 16;275(24):18153-9.

20.

Expression of the components of the insulin-like growth factor axis across the growth-plate.

Olney RC, Mougey EB.

Mol Cell Endocrinol. 1999 Oct 25;156(1-2):63-71.

PMID:
10612424
21.

Mammalian mitochondrial ribosomal proteins (2). Amino acid sequencing, characterization, and identification of corresponding gene sequences.

O'Brien TW, Fiesler SE, Denslow ND, Thiede B, Wittmann-Liebold B, Mougey EB, Sylvester JE, Graack HR.

J Biol Chem. 1999 Dec 17;274(51):36043-51.

22.
23.

Metazoan rDNA enhancer acts by making more genes transcriptionally active.

Osheim YN, Mougey EB, Windle J, Anderson M, O'Reilly M, Miller OL Jr, Beyer A, Sollner-Webb B.

J Cell Biol. 1996 Jun;133(5):943-54.

24.
25.

The terminal balls characteristic of eukaryotic rRNA transcription units in chromatin spreads are rRNA processing complexes.

Mougey EB, O'Reilly M, Osheim Y, Miller OL Jr, Beyer A, Sollner-Webb B.

Genes Dev. 1993 Aug;7(8):1609-19.

27.

Expression of mouse and frog rRNA genes: transcription and processing.

Sollner-Webb B, Pape L, Ryan K, Mougey EB, Poretta R, Nikolov E, Paalman MH, Lazdins I, Martin C.

Mol Cell Biochem. 1991 May 29-Jun 12;104(1-2):149-54. Review.

PMID:
1921993
28.

News from the nucleolus: rRNA gene expression.

Sollner-Webb B, Mougey EB.

Trends Biochem Sci. 1991 Feb;16(2):58-62. Review.

PMID:
1858134

Supplemental Content

Loading ...
Support Center